Novo Nordisk AS will lay off 11% of its global workforce and again lower its profit growth expectations

智通財經
2025.09.10 06:18
諾和諾德將在全球裁員 9,000 人，並第三次下調全年利潤預期。該公司正努力應對業績下滑帶來的挑戰。這家丹麥製藥商力爭通過裁員到 2026 年底節省 80 億丹麥克朗，裁員將影響其 11% 的員工，包括在丹麥本土的 5,000 名員工。諾和諾德表示，按固定匯率計算的全年營業利潤將增長 4% 至 10%。該公司 2 月時預測，利潤增長可能最高達 27%。諾和諾德稱，將在未來幾個月與被裁的員工進行溝通。該公司還表示，將採取其他措施來提升 “績效文化”。週三宣佈的裁員是該公司轉型計劃的一部分，旨在簡化組織結構、提高決策速度並向糖尿病、肥胖症治療等增長領域傾斜資源。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.